4 months ago
RVMD
AnalystsKelsey GoodwinKelsey Goodwin's Stock Forecasts
AnalystsKelsey Goodwin
Sectors:
Industries:
Analyst Ranking
Top 4%
#180 out of 5510 analysts
Average Return
+71.15%
Win Rate
69%27 out of 39
Risk vs Reward
Poor
Good
Kelsey Goodwin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +491.13% | $36.54 | $216.00 | 2025-08-19 - 2026-08-18 | Strong Buy |
Century Therapeutics IncIPSC | +336.04% | $0.56 | $2.42 | 2025-03-21 - 2026-03-20 | Strong Buy |
Century Therapeutics IncIPSC | +293.76% | $0.51 | $2.02 | 2025-03-28 - 2026-03-27 | Strong Buy |
Erasca IncERAS | +207.16% | $5.17 | $15.88 | 2026-01-07 - 2026-09-11 | Strong Buy |
Cg Oncology IncCGON | +198.47% | $25.56 | $76.29 | 2025-08-19 - 2026-08-18 | Strong Buy |
Kelsey Goodwin Analyst Color
Get additional color on Kelsey Goodwin's coverage of popular stocks
6 months ago
ERAS
7 months ago
RVMD
8 months ago
TNGX
8 months ago
ERAS
8 months ago
CGON
10 months ago
DAWN
a year ago
NUVL
Kelsey Goodwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cg Oncology IncCGON | 3 | Strong Buy | $85.00 | +17.48% | Maintains | a month ago |
Leonabio IncLONA | 1 | Strong Buy | $20.00 | +189.02% | Initiates Coverage On | 4 months ago |
Tango Therapeutics IncTNGX | 3 | Hold | $24.00 | +0.93% | Downgrades | 4 months ago |
Janux Therapeutics IncJANX | 3 | Strong Buy | $26.00 | +52.05% | Maintains | 4 months ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $172.00 | -15.59% | Maintains | 4 months ago |
Summit Therapeutics IncSMMT | 2 | Hold | $16.00 | -8.83% | Maintains | 4 months ago |
Relmada Therapeutics IncRLMD | 1 | Strong Buy | $12.00 | +165.49% | Initiates Coverage On | 6 months ago |
Erasca IncERAS | 3 | Strong Buy | $18.00 | +13.35% | Maintains | 6 months ago |
Arcellx IncACLX | 4 | Hold | $115.00 | -0.06% | Downgrades | 7 months ago |
Black Diamond Therapeutics IncBDTX | 2 | Strong Buy | $8.00 | +304.04% | Maintains | 8 months ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $24.00 | +528.27% | Initiates Coverage On | 8 months ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $22.00 | +82.72% | Initiates Coverage On | 8 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $26.00 | +20.76% | Maintains | 10 months ago |
Nuvalent IncNUVL | 4 | Strong Buy | $128.00 | +3.26% | Maintains | a year ago |
Urogen Pharma LtdURGN | 4 | Strong Buy | $36.00 | N/A | Initiates Coverage On | a year ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | a year ago |
Century Therapeutics IncIPSC | 3 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Genelux CorpGNLX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Macrogenics IncMGNX | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
2seventy Bio IncTSVT | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Iovance Biotherapeutics IncIOVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.